COVID-19: Vaccines and Therapeutics
State-licensed pharmacists and state-authorized pharmacy interns under their supervision may administer COVID-19 vaccines and tests authorized or licensed by the Food and Drug Administration, subject to certain requirements, the Department of Health and Human Services said in guidance.
Moderna Inc., announced the completion of enrollment for its COVID-19 vaccine phase 3 trial.
The Department of Health and Human Services announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to long-term care facility residents.
The Centers for Disease Control and Prevention added vaccine information to its COVID-19 webpage.
A new poll by Gallup is showing sharp declines in Americans’ willingness to be vaccinated for the SARS-CoV-2 coronavirus.
Drug maker Johnson & Johnson Oct. 12 announced the pause of its large-scale, pivotal, multi-country phase 3 trial for its JNJ-78436735 COVID-19 vaccine candidate.
The Food and Drug Administration released guidance and a briefing document outlining the key data needed to support an emergency use authorization for a COVID-19 vaccine candidate and further explaining the EUA process.
The National Academies of Science, Engineering and Medicine released A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus to assist and guide the federal government and decision-making bodies, including the Advisory Committee on Immunization Practices, as well as state, tribal…
Joint AHA, AAMC Statement on NASEM Report on Equitable Allocation of a COVID-19 Vaccine.
An experimental mRNA vaccine for the COVID-19 virus generated a strong immune response in older adults in a phase 1 clinical trial, who generally tolerated it well, the National Institutes of Health reports.